跳至主導覽
跳至搜尋
跳過主要內容
長庚大學學術能量集萃 首頁
說明與常見問題
English
中文
首頁
學者概覽
研究單位
研究產出
研究計畫-專案
獎項
活動
新聞/媒體
按專業知識、姓名或所屬機構搜尋
Dupilumab for STAT3-Hyper-IgE Syndrome With Refractory Intestinal Complication.
Chun-Wei Lu, Wen I. Lee, Wen-Hung Chung
醫學系
研究成果
:
期刊稿件
›
文章
›
同行評審
10
引文 斯高帕斯(Scopus)
總覽
指紋
指紋
深入研究「Dupilumab for STAT3-Hyper-IgE Syndrome With Refractory Intestinal Complication.」主題。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Complication
100%
Immunoglobulin E
100%
Diarrhea
100%
Syndrome
100%
Patient
75%
Hyperimmune Globulin
75%
Skin
50%
Immune Deficiency
50%
Eczema
50%
Gastrointestinal Distress
50%
Intestine Perforation
50%
Therapeutic Procedure
25%
Surgery
25%
Life
25%
Serum
25%
Antibiotics
25%
Gut
25%
Plummer-Vinson Syndrome
25%
Steroid Treatment
25%
Threat
25%
Dermatitis
25%
Abscess
25%
Man
25%
Next Generation Sequencing
25%
Abdominal Pain
25%
Gastroesophageal Reflux
25%
Isoprenaline
25%
Intravenous Immunoglobulin Therapy
25%
Immunomodulating Agent
25%
Respiratory Tract Infection
25%
Immunology and Microbiology
STAT3
100%
Hyper IgE Syndrome
100%
Dupilumab
100%
Skin
60%
Hyperimmunoglobulin E Syndrome
60%
Inflammation
40%
Immunodeficiency
40%
Life
20%
Immunoglobulin E
20%
Mutation
20%
Colon
20%
Time
20%
Eczema
20%
Immunoglobulin Blood Level
20%
Immunomodulating Drugs
20%
Dermatitis
20%
Esophagitis
20%